CardioPractice Cardio Talk – Details, episodes & analysis

With Panos E. Vardas, Department at Heraklion University, Hospital, Crete - Greece & Marc Ferrini, Editor-in-Chief CardioPractice; CH Saint Joseph and Saint Luc, Lyon - France.

In this podcast, Professor Panos E. Vardas (Department at Heraklion University, Hospital, Crete, Greece) joins Dr Marc Ferrini (CH Saint Joseph and Saint Luc, Lyon, France) to discuss how artificial intelligence can modify our daily cardiology practice.

With Nicolaus Marx, WTH University Hospital Aachen, Aachen - Germany & Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.
 
In this podcast, Professor Nicolaus Marx (WTH University Hospital Aachen, Aachen, Germany), Chair of Task Force of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes;  joins Associate Professor Ruxandra Christodorescu (University of Medicine and Pharmacy Victor Babes, Timisoara, Romania) to discuss lipids and diabetes.

With Dimitris RICHTER, Euroclinic of Athens, Athens - Greece & Heinz DREXEL, Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch - Austria.

In this podcast, Professor Heinz Drexel (Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch, Austria) joins Dr Dimitris Richter (Euroclinic of Athens, Athens, Greece) to discuss hypertriglyceridemia and residual cardiovascular risk.

1. Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. N Engl J Med. 2022 Nov 24;387(21):1923-1934.
2. Sosnowska B, Adach W, Surma S, Rosenson RS, Banach M. Evinacumab, an ANGPTL3 Inhibitor, in the Treatment of Dyslipidemia. J Clin Med. 2022 Dec 25;12(1):168. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821629/
3. Gaba P, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Tardif JC, Giugliano RP, Martens FMAC, Gibson CM, Ballantyne CM; REDUCE-IT Investigators. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction. J Am Coll Cardiol. 2022 May 3;79(17):1660-1671. https://www.sciencedirect.com/science/article/pii/S0735109722005538?via%3Dihub
4. Drexel H, Tamargo J, Kaski JC, Lewis BS, Saely CH, Fraunberger P, Dobrev D, Komiyama M, Plattner T, Agewall S, Hasegawa K. Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease? Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):570-582. https://academic.oup.com/ehjcvp/article/9/6/570/7199773?login=false
5. ACCORD Study Group; Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29;362(17):1563-74. https://www.nejm.org/doi/10.1056/NEJMoa1001282?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200www.ncbi.nlm.nih.gov

With Harald Jorstad, Amsterdam UMC - The Netherlands and Michael Papadakis, St. George’s, University of London and St George’s Hospitals NHS Foundation Trust, London - UK.  
  
In this podcast, Dr Harald Jorstad (Amsterdam UMC, The Netherlands) is joined by Professor Michael Papadakis (St. George’s, University of London and St George’s Hospitals NHS Foundation Trust, London, UK) to discuss risk stratification in sports cardiology. 

With Harald Jorstad, Amsterdam UMC - The Netherlands and Maria Sanz de la Garza, Hospital Clinic Barcelona, Barcelona - Spain.
  
In the second of two podcasts, Dr Harald Jorstad (Amsterdam UMC, the Netherlands) joins Dr Maria Sanz de la Garza (Hospital Clínic de Barcelona, Barcelona, Spain) to discuss the role of imaging for the prevention of sudden cardiac death with a focus on multimodality imaging in aortopathies and ischaemic heart disease. 

With Harald Jorstad, Amsterdam UMC - The Netherlands and Maria Sanz de la Garza, Hospital Clinic Barcelona, Barcelona - Spain. 

In the first of two podcasts, Dr Harald Jorstad (Amsterdam UMC, the Netherlands) joins Dr Maria Sanz de la Garza (Hospital Clínic de Barcelona, Barcelona, Spain) to discuss the role of imaging for the prevention of sudden cardiac death with a focus on multimodality imaging in cardiomyopathies. 

With Harald Thune Jørstad (host), Amsterdam UMC, Amsterdam - The Netherlands & Flavio D'Ascenzi, University of Siena, Siena - Italy.

In this podcast, Dr Harald Thune Jørstad (Amsterdam UMC, Amsterdam, The Netherlands) and Assoc. Prof. Flavio D’Ascenzi (University of Siena, Siena, Italy) discuss exercise prescription in athletes with cardiomyopathies.

With Harald Thune Jørstad (host), Amsterdam UMC, Amsterdam - The Netherlands, Jolien Roos-Hesselink2, Erasmus MC, Rotterdam -The Netherlands  & Dr.Martijn Kauling, Erasmus MC, Rotterdam - The Netherlands.

In this podcast, Dr Harald Thune Jørstad (Amsterdam UMC, Amsterdam, The Netherlands), Prof. Jolien Roos-Hesselink and Dr.Martijn Kauling (Erasmus MC, Rotterdam, The Netherlands) discuss physical exercising for cardiovascular prevention.